BofA reiterates Buy on ASML stock, keeps $2,268 price target

BofA Securities reiterated a Buy on ASML and kept its $2,268 price target, arguing 2030 revenue could exceed the company’s €44B-€60B guide and potentially reach €73B. Under that scenario, BofA sees gross margin above 60%, EBIT margins near 50%, and EPS above €90 by around 2030, versus ASML’s trailing 12-month gross margin of 52.6%. The article also notes a €79.4M share buyback and continued strong analyst support, though the stock is already up 128% over the past year and trades at 58.31x earnings.

Analysis

The key second-order effect is that this is no longer just a "good demand" story; it is a margin convexity story. If ASML can push revenues materially above the current long-range framework, the operating leverage from a largely fixed manufacturing and R&D base should compound faster than consensus expects, which is exactly the kind of setup where sell-side models lag by 12-24 months. That makes the stock less about the next quarter and more about whether 2027-2030 capacity additions at customers and the broader lithography bottleneck remain intact.

Competitively, the biggest beneficiaries are not just ASML shareholders but the entire EUV ecosystem: upstream optics, precision components, and installed-base service providers should see a longer runway if customers continue to prioritize leading-edge node transitions. Conversely, lower-priced alternatives are most dangerous in mature-node or secondary tool markets, but that threat is more about share leakage at the margin than about displacing the high-NA/EUV moat near term. The more relevant risk is capital spending cyclicality at the foundry and memory layer—if AI-related fab build-outs slow, the market will compress the time horizon from "2030 earnings power" back to "next 2-4 quarters."

The contrarian miss is valuation duration risk: the market may be treating the revenue upside as if it arrives linearly, when in reality the multiple can de-rate long before the earnings inflect if investors start to doubt shipment timing or China exposure. With the stock already pricing in strong execution, the asymmetry is less compelling for outright longs here than for structured expressions that monetize upside while protecting against multiple compression. The catalyst to watch is not just orders, but whether management commentary begins to validate the higher end of the long-term revenue envelope earlier than expected; that would force analysts to raise terminal margin assumptions, not merely top-line estimates.

Key Decisions for Investors

• Prefer a call spread in ASML over cash equity: buy 12-18 month upside optionality while limiting damage if the market keeps the multiple pinned; best risk/reward if the stock consolidates after the recent run.
• Pair trade: long ASML / short a weaker semi-capex beneficiary with lower moat and higher customer concentration (e.g., INTC) over 3-6 months; thesis is that EUV scarcity captures more durable pricing power than general foundry recovery.
• If already long ASML, finance the position with covered calls 10-15% above spot on 1-3 month tenor to harvest elevated implied vol while the market digests the valuation.
• Use any post-earnings or macro-driven pullback to build ASML exposure only if the stock de-rates faster than fundamentals; otherwise avoid adding above current multiples, where upside depends on perfect execution.
• Watch for a corroborating move in European semi-cap suppliers (BCS-linked industrial/financial proxies aside), and add only if capital-spending breadth confirms ASML is not a single-name rerating.